31.2 C
New York
Thursday, July 3, 2025

Tag: US02155H1014

Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26

Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.
Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsUS02155H1014